Pergunte ao Google

Você procurou por: edetate (Francês - Inglês)

Contribuições humanas

A partir de tradutores profissionais, empresas, páginas da web e repositórios de traduções disponíveis gratuitamente

Adicionar uma tradução

Francês

Inglês

Informações

Francês

Edetate Calcium Disodium

Inglês

List of Acceptable Non-medicinal Ingredients

Última atualização: 2015-05-14
Frequência de uso: 1
Qualidade:

Francês

EMULSIONS HUILE DANS EAU CONTENANT DU PROPOFOL ET DE L'EDETATE

Inglês

OIL IN WATER EMULSIONS CONTAINING PROPOFOL AND EDETATE

Última atualização: 2011-07-27
Frequência de uso: 4
Qualidade:

Francês

DEQUALINIUM CHLORIDE METHOTREXATE PIPRADROL HYDROCHLORIDE VINCRISTINE SULFATE THIOTEPA CALCIUM DISODIUM EDETATE

Inglês

PIPRADROL HYDROCHLORIDE VINCRISTINE SULFATE THIOTEPA CALCIUM DISODIUM EDETATE

Última atualização: 2015-05-14
Frequência de uso: 1
Qualidade:

Francês

EMULSIONS HUILE DANS L'EAU CONTENANT DU PROPOFOL ET DE L'EDETATE DISODIQUE

Inglês

OIL IN WATER EMULSIONS CONTAINING PROPOFOL AND DISODIUM EDETATE

Última atualização: 2014-11-25
Frequência de uso: 3
Qualidade:

Aviso: contém formatação HTML invisível

Francês

Description d'ingrédient COIX LACRYMA-JOBI (JOB'S TEARS) SEED EXTRACTFIBRONECTIN
IMPERATA CYLINDRICA ROOT EXTRACT
RAHNELLA / SOY PROTEIN FERMENT
ECHIUM PLANTAGINEUM SEED OIL
MARITIME PINE OIL
POPPY PETAL EXTRACT, RED
INFUSION OF PASSIONFLOWER
CINNAMON WOOD
NATURAL BORNEOL EXTRACT, CRYSTALIZED
PETIT GRAIN PARAGUAY OIL
HYDROLYZED RNA
LYSINE HYDROXYPROPYLTRIMONIUM CHLORIDE
BARLEY WATER
COPPER DISODIUM EDETATE
QUILLAJA
RED CLOVER
WHOLE RED CLOVER
RED CLOVER BLOSSOM EXTRACT
LINSEED EXTRACT
LOVAGE ROOT POWDER
CHINESE LOVAGE FLOWERS EXTRACT
SAGE FLOWER
SAGE POWDER
SODIUM CARBONATE, ANHYDROUS
SODIUM CARBONATE, EXSICCATED
ARNICA FLOWERS
ARNICA FLOWERS EXTRACT
PEG-75 COCOA BUTTER GLYCERIDES
WHITE WILLOW BARK
ANETHUM SOWA
MARJORAM OIL, MEXICAN
CARIBBEAN SEAWEED INFUSION
LAURYLDIMONIUM HYDROLYZED ANIMAL PROTEIN
HUMAN HAIR KERATIN PROTEIN
PURIFIED SPRING WATER
PURIFIED WATER, USP
COSTA RICAN SPRING WATER
R.O. WATER
CAUTERETS SPRING WATER
SD ALCOHOL
*AETHANOLUM 94% (maybe ethanol???)

Inglês

Ingredient Description COIX LACRYMA-JOBI (JOB'S TEARS) SEED EXTRACTFIBRONECTIN
IMPERATA CYLINDRICA ROOT EXTRACT
RAHNELLA / SOY PROTEIN FERMENT
ECHIUM PLANTAGINEUM SEED OIL
MARITIME PINE OIL
POPPY PETAL EXTRACT, RED
INFUSION OF PASSIONFLOWER
CINNAMON WOOD
NATURAL BORNEOL EXTRACT, CRYSTALIZED
PETIT GRAIN PARAGUAY OIL
HYDROLYZED RNA
LYSINE HYDROXYPROPYLTRIMONIUM CHLORIDE
BARLEY WATER
COPPER DISODIUM EDETATE
QUILLAJA
RED CLOVER
WHOLE RED CLOVER
RED CLOVER BLOSSOM EXTRACT
LINSEED EXTRACT
LOVAGE ROOT POWDER
CHINESE LOVAGE FLOWERS EXTRACT
SAGE FLOWER
SAGE POWDER
SODIUM CARBONATE, ANHYDROUS
SODIUM CARBONATE, EXSICCATED
ARNICA FLOWERS
ARNICA FLOWERS EXTRACT
PEG-75 COCOA BUTTER GLYCERIDES
WHITE WILLOW BARK
ANETHUM SOWA
MARJORAM OIL, MEXICAN
CARIBBEAN SEAWEED INFUSION
LAURYLDIMONIUM HYDROLYZED ANIMAL PROTEIN
HUMAN HAIR KERATIN PROTEIN
PURIFIED SPRING WATER
PURIFIED WATER, USP
COSTA RICAN SPRING WATER
R.O. WATER
CAUTERETS SPRING WATER
SD ALCOHOL
*AETHANOLUM 94% (maybe ethanol???)

Última atualização: 2015-05-14
Frequência de uso: 1
Qualidade:

Francês

Description d'ingrédient COIX LACRYMA-JOBI (JOB'S TEARS) SEED EXTRACT FIBRONECTIN IMPERATA CYLINDRICA ROOT EXTRACT RAHNELLA / SOY PROTEIN FERMENT ECHIUM PLANTAGINEUM SEED OIL MARITIME PINE OIL POPPY PETAL EXTRACT, RED INFUSION OF PASSIONFLOWER CINNAMON WOOD NATURAL BORNEOL EXTRACT, CRYSTALIZED PETIT GRAIN PARAGUAY OIL HYDROLYZED RNA LYSINE HYDROXYPROPYLTRIMONIUM CHLORIDE BARLEY WATER COPPER DISODIUM EDETATE QUILLAJA RED CLOVER WHOLE RED CLOVER RED CLOVER BLOSSOM EXTRACT LINSEED EXTRACT LOVAGE ROOT POWDER CHINESE LOVAGE FLOWERS EXTRACT SAGE FLOWER SAGE POWDER SODIUM CARBONATE, ANHYDROUS SODIUM CARBONATE, EXSICCATED ARNICA FLOWERS ARNICA FLOWERS EXTRACT PEG-75 COCOA BUTTER GLYCERIDES WHITE WILLOW BARK ANETHUM SOWA MARJORAM OIL, MEXICAN CARIBBEAN SEAWEED INFUSION LAURYLDIMONIUM HYDROLYZED ANIMAL PROTEIN HUMAN HAIR KERATIN PROTEIN PURIFIED SPRING WATER PURIFIED WATER, USP COSTA RICAN SPRING WATER R.O. WATER CAUTERETS SPRING WATER SD ALCOHOL *AETHANOLUM 94% (maybe ethanol???)

Inglês

Ingredient Description COIX LACRYMA-JOBI (JOB'S TEARS) SEED EXTRACT FIBRONECTIN IMPERATA CYLINDRICA ROOT EXTRACT RAHNELLA / SOY PROTEIN FERMENT ECHIUM PLANTAGINEUM SEED OIL MARITIME PINE OIL POPPY PETAL EXTRACT, RED INFUSION OF PASSIONFLOWER CINNAMON WOOD NATURAL BORNEOL EXTRACT, CRYSTALIZED PETIT GRAIN PARAGUAY OIL HYDROLYZED RNA LYSINE HYDROXYPROPYLTRIMONIUM CHLORIDE BARLEY WATER COPPER DISODIUM EDETATE QUILLAJA RED CLOVER WHOLE RED CLOVER RED CLOVER BLOSSOM EXTRACT LINSEED EXTRACT LOVAGE ROOT POWDER CHINESE LOVAGE FLOWERS EXTRACT SAGE FLOWER SAGE POWDER SODIUM CARBONATE, ANHYDROUS SODIUM CARBONATE, EXSICCATED ARNICA FLOWERS ARNICA FLOWERS EXTRACT PEG-75 COCOA BUTTER GLYCERIDES WHITE WILLOW BARK ANETHUM SOWA MARJORAM OIL, MEXICAN CARIBBEAN SEAWEED INFUSION LAURYLDIMONIUM HYDROLYZED ANIMAL PROTEIN HUMAN HAIR KERATIN PROTEIN PURIFIED SPRING WATER PURIFIED WATER, USP COSTA RICAN SPRING WATER R.O. WATER CAUTERETS SPRING WATER SD ALCOHOL *AETHANOLUM 94% (maybe ethanol???)

Última atualização: 2015-05-14
Frequência de uso: 1
Qualidade:

Francês

Nom usuel en anglais (dénomination commune) Edetate Disodium Nom propre Disodium [{2 - [bis ( carboxymethyl ) amino]ethyl} ( carboxymethyl ) amino]acetate Source/forme (si tel est le cas) Synthétique Nom usuel en français (dénomination commune) Sel disodique de l'acide éthylènediaminetétracétique Nom chimique et numéro de registre CAS Glycine, N,N' - 1,2 - ethyanediylbis[N - ( carboxymethyl ) - , disodium salt, dihydrate; disodium ( ethylenedinitrilo ) tetraacetate dihydrate [6381 - 92 - 6]; [139 - 33 - 3] ( anhydre ) ; [60 - 00 - 4] ( edetic acid ) ] Synonymes/formule Sel disodique de l'acide éthylènediaminetétracétique; ethylenebis ( iminodiacetic acid ) disodium salt; edetic acid disodium salt; eathamil disodium; disodium edathamil; EDTA disodium; tetracemate disodium; disodium ethylenediaminetetraacetate; disodium edetate; Cheladrate; Chelaplex III; Endrate disodium; Sequestrene NA 2; Sodium Versenate; Titriplex III; Versene disodium salt.

Inglês

Chemical Name and CAS Registry number Glycine, N,N' - 1,2 - ethyanediylbis[N - ( carboxymethyl ) - , disodium salt, dihydrate; disodium ( ethylenedinitrilo ) tetraacetate dihydrate [6381 - 92 - 6]; [139 - 33 - 3] ( anhydrous ) ; [60 - 00 - 4] ( edetic acid ) ] Synonyms/ Formula Ethylenediaminetetraacetic acid disodium salt; ethylenebis ( iminodiacetic acid ) disodium salt; edetic acid disodium salt; eathamil disodium; disodium edathamil; EDTA disodium; tetracemate disodium; disodium ethylenediaminetetraacetate; disodium edetate; Cheladrate; Chelaplex III; Endrate disodium; Sequestrene NA 2; Sodium Versenate; Titriplex III; Versene disodium salt.

Última atualização: 2015-05-14
Frequência de uso: 1
Qualidade:

Francês

Nom usuel en anglais (dénomination commune) Edetate Calcium Disodium Nom propre Calciate ( 2 - ) , [[N,N' - 1,2 - ethanediylbis[N - caxoymethyl ) glycinoato]] ( 4 - ) - N,N',O,O',ON, On'] - , disodium, hydrate, ( oC - 6 - 21 ) - ; Source/forme (si tel est le cas) Synthétique Nom usuel en français (dénomination commune) Calciate ( 2 - ) , [[N,N' - 1,2 - ethanediylbis[N - caxoymethyl ) glycinoato]] ( 4 - ) - N,N',O,O',ON, On'] - , disodium, hydrate, ( oC - 6 - 21 ) - ; Nom chimique et numéro de registre CAS Calciate ( 2 - ) , [[N,N' - 1,2 - ethanediylbis[N - caxoymethyl ) glycinoato]] ( 4 - ) - N,N',O,O',ON, On'] - , disodium, hydrate, ( oC - 6 - 21 ) - ; disodium[ ( ethylenedinitrilo ) tetraacetato]calciate ( 2 - ) hydrate [23411 - 34 - 9]; [62 - 33 - 9] ( anhydrous ) ; [60 - 00 - 4] ( edetic acid ) Synonymes/formule Chélate d'éthylènediaminetétraacétate de calcium et de disodium; calcium disodium ( ethylenedinitrilo ) - tetraacetate; calcium disodium ethylenediaminetetraacetate; EDTA calcium; edathamil calcium disodium salt; sodium calciumedetate; Calcitetracemate Disodium; Calcium Disodium Versenate; Ledclair; Mosatil; Antallin; Sormetal; Versene CA.

Inglês

Chemical Name and CAS Registry number Calciate ( 2 - ) , [[N,N' - 1,2 - ethanediylbis[N - caxoymethyl ) glycinoato]] ( 4 - ) - N,N',O,O',ON, On'] - , disodium, hydrate, ( oC - 6 - 21 ) - ; disodium[ ( ethylenedinitrilo ) tetraacetato]calciate ( 2 - ) hydrate [23411 - 34 - 9]; [62 - 33 - 9] ( anhydrous ) ; [60 - 00 - 4] ( edetic acid ) Synonyms/ Formula Ethylenediaminetetraacetic acid calcium disodium chelate; calcium disodium ( ethylenedinitrilo ) - tetraacetate; calcium disodium ethylenediaminetetraacetate; EDTA calcium; edathamil calcium disodium salt; sodium calciumedetate; Calcitetracemate Disodium; Calcium Disodium Versenate; Ledclair; Mosatil; Antallin; Sormetal; Versene CA.

Última atualização: 2015-05-14
Frequência de uso: 1
Qualidade:

Francês

Acide azélaïque Acide azélaïque 15 % Gel Topique 2270811 Agent de traitement de la rosacée Acide benzoïque, edetate de disodium, lécithine, triglycérides à chaîne moyenne, acide polyacrylique, polysorbate 80, propylèneglycol, hydroxyde de sodium, eau purifiée Présentation de drogue nouvelle, no de contrôle 092975 2004/07/26 2005/09/02

Inglês

Azelaic acid Azelaic acid 15% Gel Topical 02270811 Anti-rosacea agent Benzoic acid, disodium edetate, lecithin, medium-chain triglycerides, polyacrylic acid, polysorbate 80, propylene glycol, sodium hydroxide, purified water New Drug Submission, Control No. 092975 2004/07/26 2005/09/02

Última atualização: 2015-05-14
Frequência de uso: 1
Qualidade:

Francês

Sel disodique de l'acide Agent complexant, chélateur; éthylènediaminetétracétique; anticoagulant ethylenebis(iminodiacetic acid) disodium salt; edetic acid disodium salt; eathamil disodium; disodium edathamil; EDTA disodium; tetracemate disodium; disodium ethylenediaminetetraacetate; disodium edetate; Cheladrate; Chelaplex III; Endrate disodium; Sequestrene NA 2; Sodium Versenate; Titriplex III; Versene disodium salt.

Inglês

Ethylenediaminetetraacetic Chelating Agent; colour acid calcium disodium retention agent in foods or chelate; calcium disodium flavoring agent (ethylenedinitrilo)tetraacetate; calcium disodium ethylenediaminetetraacetate; EDTA calcium; edathamil calcium disodium salt; sodium calciumedetate; Calcitetracemate Disodium; Calcium Disodium Versenate; Ledclair; Mosatil; Antallin; Sormetal; Versene CA.

Última atualização: 2015-05-14
Frequência de uso: 1
Qualidade:

Francês

Ingrédient médicinal Acide azélaïque Nom générique international Acide azélaïque Concentrations 15 % Forme posologique Gel Voie d'administration Topique DIN 2270811 Classe pharmacothérapeutique (classe ATC) Agent de traitement de la rosacée Ingrédients non médicinaux Acide benzoïque, edetate de disodium, lécithine, triglycérides à chaîne moyenne, acide polyacrylique, polysorbate 80, propylèneglycol, hydroxyde de sodium, eau purifiée Type et numéro de présentation Présentation de drogue nouvelle, n° de contrôle 092975 Date de la présentation 2004/07/26 Date de l'autorisation 2005/09/02 2 AVIS DE DÉCISION Le 2 septembre 2005, Santé Canada a émis, à l'intention de Berlex Canada Inc., un avis de conformité du produit thérapeutique Finacea.

Inglês

Medicinal Ingredient Azelaic acid International Non-proprietary Name Azelaic acid Strengths 15% Dosage form Gel Route of Administration Topical DIN 02270811 Pharmaco-therapeutic group (ATC Code) Anti-rosacea agent Non-medicinal Ingredients Benzoic acid, disodium edetate, lecithin, medium-chain triglycerides, polyacrylic acid, polysorbate 80, propylene glycol, sodium hydroxide, purified water Submission Type and Control No. New Drug Submission,Control No. 092975 Date of Submission 2004/07/26 Date of Authorization 2005/09/02 2 NOTICE OF DECISION On September 2, 2005, Health Canada issued a Notice of Compliance to Berlex Canada Inc. for the drug product Finacea.

Última atualização: 2015-05-14
Frequência de uso: 1
Qualidade:

Francês

Gel ophthalmique présentant la composition suivante : Gomme de xanthane : 0,1 à 5 %, avantageusement 0,7 à 1,5 % en poids ; Cromoglicate de disodium : 0,5 à 5 % avantageusement environ 2 % en poids ; Sorbitol : 1 à 7 %, de préférence 3 à 4,5 % en poids ; Centrimid : 0,001 à 0,1 %, de préférence 0,008 à 0,02 % en poids ; Edetate de sodium : 0,001 à 0,1 %, avantageusement 0,008 à 0,2 % en poids.

Inglês

Ophthalmic gel preparation with the following composition: Xanthane gum 0.1 - 5 wt.-%, preferably 0.7 - 1.5 wt.-% Disodium cromoglicate 0.5 - 5 wt.-%, preferably approximately 2 wt.-% Sorbitol 1 - 7 wt.-%, preferably 3 - 4.5 wt.-% Centrimid 0.001 - 0.1 wt.-%, preferably 0.008 - 0.02 wt.-% Na-Edetate 0.001 - 0.1 wt.-%, preferably 0.008 - 0.2 wt.-%.

Última atualização: 2014-12-04
Frequência de uso: 1
Qualidade:

Francês

Solution selon la revendication 1, comprenant de l'hyoscine-N-butylbromide, du lidocaine HCl, du disodium edetate, du disodium dibasique phosphate, du Nipagin A et du Nipasol M. Solution selon n'importe quelle revendication ou n'importe quelle combinasion de revendications 1-3 comprenant des substances actives comme de l'hyoscine-N-butylbromide ou codeine phosphate.

Inglês

Solution according to claim 1 comprising hyoscine-N-butylbromide, lidocaine HCl, disodium edetate, disodium dibasic phosphate, nipagin A and nipasol M. Solution according to anyone or any combination of claims 1-3, including active substances such as hyoscine-N-butylbromide or codeine phosphate.

Última atualização: 2014-12-04
Frequência de uso: 1
Qualidade:

Francês

Solution selon la revendication 1, convenable pour des ampoules à 4ml comprenant 600mg de paracétamole, 20mg de lidocaine HCI, 4mg disodium edetate, du disodium dibasique phosphate q.s., 2mg de sodium métabisulfite, 1.5mg de glycerole formale, 0.4mg de l'alcool benzylique, q.s. de l'eau, la dite solution comprenant de manière facultative à la fois de l'hyoscine-N-butylbromide ainsi de le mélange Nipagin A et Nipasol M. Solution selon la revendication 1, convenable pour une solution dans une ampoule à 4ml comprenant 600mg de paracétamole, 20mg de l'hyoscine-N-butylbromide, 20mg de lidocaine HCI, 0.4mg de disodium edetate, du disodium dibasique phosphate q.s., 1.8mg de Nipagin A, 0.2mg Nipasol M, 0.4mg de l'alcool benzylique, 1.5ml de glycérole formale, de l'eau q.s., la dite solution contenant de manière facultative 30mg ou 15mg de codéine phosphate.

Inglês

Solution according to claim 1 suitable for 4ml ampoule, comprising 600mg paracetamol, 20mg lidocaine HCl, 4mg disodium edetate, disodium dibasic phosphate q.s., 2mg sodium metabisulfite, 1.5mg glycerol formal, 0.4mg benzyl alcohol, q.s. water, said solution optionally, comprising both hyoscine-N-butylbromide as well as the mixture nipagin A and nipasol M. Solution according to claim 1 suitable for 4ml ampoule solution comprising 600mg paracetamol, 20mg hyoscine-N-butylbromide, 20mg lidocaine HCl, 0.4mg disodium edetate, disodium dibasic phosphate q.s., 1.8mg nipagin A, 0.2mg nipasol M, 0.4ml benzyl alcohol, 1.5ml glycerol formal, water q.s. said solution optionally comprising 30mg or 15mg codeine phosphate.

Última atualização: 2014-12-04
Frequência de uso: 1
Qualidade:

Francês

Exemple 4 Phase A Diisopropyl adipate 15,00 % Ceteareth 20 0,25 % PPG 15 Stearyl ether vendu sous le nom de Arlamol E 5 % Propyl Paraben 0,05 % phase B Eau qsp 100 % Propylène glycol 3,00 % Edetate disodique 0,10 % Methyl Paraben 0,10 % Phase C acide 3-(3,5,5,8,8-pentaméthyl-5,6,7,8-tetrahydro-2-naphtyl)phenyl acrylique 1,00 % Poloxamer 182 2,00 % Propylène glycol 2,00 % Copolymère d'acide acrylique et d'alkylmethacrylate 0,35 % Carbomer 980 0,10 % Chlorure de Benzalkonium 0,10 % Hydroxyde de sodium à 10% qs pH 5,5 Mode opératoire : Le mode opératoire utilisé est analogue au mode opératoire de l'exemple 1.

Inglês

EXAMPLE 4 [0110] [0111] Procedure: [0112] The procedure was essentially the procedure of Example 1.

Última atualização: 2014-12-03
Frequência de uso: 1
Qualidade:

Francês

Exemple 5 Phase A isopropyl palmitate 12,00 % Ceteareth 20 0,40 % cyclométhicone 5 % Propyl Paraben 0,10 % phase B Eau purifiée qsp 100 % Propylène glycol 2,00 % Edetate disodique 0,10 % Copolymère d'acide acrylique et d'alkylmethacrylate 0,35 % Carbomer 980 0,25 % Phenoxyethanol 1,00 % Phase C Nadifloxacine 1,00 % Poloxamer 124 2,00 % Propylène glycol 2,00 % Hydroxyde de sodium à 10% qs pH 5,5 Mode opératoire : Le mode opératoire utilisé est similaire au mode opératoire de l'exemple 1.

Inglês

EXAMPLE 5 [0114] [0115] Procedure: [0116] The procedure was essentially the procedure of Example 1.

Última atualização: 2014-12-03
Frequência de uso: 1
Qualidade:

Francês

Exemple 2 Phase A Isohexadecane 5,00 % Polyisobutène hydrogéné 12,00 % propyl paraben 0,10 % Sorbitan sesquiolate 0,15 % Ceteareth 20 0,25 % Phase B Eau , qsp 100 % Propylène glycol 2,00 %> Edetate disodique 0,10 % Methyl paraben 0,10 % Phase C Nadifloxacine 1,00 % Poloxamer 124 2,00 % Propylène glycol 2,00 % Copolymère d'acide acrylique et d'alkylmethacrylate 0,35 % carbomer 0,10 % Hydroxyde de sodium à 10%> qs pH 5,5 % Mode opératoire : Le mode opératoire utilisé est analogue au mode opératoire de l'exemple 1.

Inglês

EXAMPLE 2 [0102] [0103] Procedure: [0104] The procedure was essentially the procedure of Example 1.

Última atualização: 2014-12-03
Frequência de uso: 1
Qualidade:

Aviso: contém formatação HTML invisível

Francês

A- EXEMPLES DE FORMULATIONS Exemple 1 Phase A Glycéryl stéarate et PEG 100 stéarate 5,00 % Polyisobutène hydrogéné 11,00 % propyl paraben 0,10 % acide stéarique 2,00 % Phase B Eau qsp 100 % Propylène glycol 2 % Edetate disodique 0,10 % Methyl paraben 0,10 % Phase C Nadifloxacine 1,00 % Poloxamer 124 2,00 % Propylène glycol 2,00 % Copolymère d'acide acrylique et d'alkylmethacrylate 0,20 % cyclométhicone 3,00 % Hydroxyde de sodium à 10%) qs pH 5,5 Mode opératoire : On pèse les composés de la phase B et on les met sous agitation en chauffant.

Inglês

[0095] The following Examples 1-5 provide representative specific formulations according to the present invention. EXAMPLE 1 [0096] [0097] Procedure: [0098] The components of phase B were weighed and stirred with heating.

Última atualização: 2014-12-03
Frequência de uso: 1
Qualidade:

Francês

Exemple 3 Phase A Diisopropyl adipate 12,00 % Ceteareth 20 0,25 % phase B Eau qsp 100 % Propylène glycol 2,00 % Edetate disodique 0,10 % Chlorure de Benzalkonium 0,05 % Phase C Nadifloxacine 1,00 % Poloxamer 124 2,00 % Propylène glycol 2,00 % Copolymère d'acide acrylique et d'alkylmethacrylate 0,35 %> Carbomer 980 0,30 % cyclométhicone 5 % Hydroxyde de sodium à 10%> qs pH 5,5 Mode opératoire : Le mode opératoire utilisé est analogue au mode opératoire de l'exemple 1.

Inglês

EXAMPLE 3 [0106] [0107] Procedure: [0108] The procedure was essentially the procedure of Example 1.

Última atualização: 2014-12-03
Frequência de uso: 1
Qualidade:

Aviso: contém formatação HTML invisível

Francês

Les pourcentages sont des pourcentages en poids. 1 - Exemple de formulations DOW CORNING 3225 C 10,00 g DECAMETHYL CYCLOPENTASILOXANE 1 à 10 g PATE DE TITANE 1 à 50 g SPECTRAVEIL MOTG 0,1 à 20 g VASELINE BLANCHE QUALITE A 1,000 g BENTONE 38 STERILISEE 0, 1 à 2 g MONOSTEARATE DE GLYCEROL 0,1 à 2 g MONOMULS 0L12 0,1 à 2 g ACETATE D'ALPHA TOCOPHEROL 0,500 g NaCl SUPER EPURE DESULFATE 2,000 g KELTROL T.F. 0, 150 g WITCONOL APM 0,800 g PARAHYDROXY BENZOATES 0,600 g EUXYL K 400 0, 100 g GLYCEROL 8,000 g EDETATE DISODIQUE PH EU 0,200 g MELANGE PIGMENTAIRE 17123 2,000 g PARFUM 0,100 g AEROSIL R972 SILICE COLLOÏDE 0,100 a 1 g BU TYL HYDROXY TOLUENE 0,0100 g EAU THERMALE D'AVENE qsp 100,00 g On indique que : - le MONOMULS 90L12 est du monolaurate de glycérol (HENKEL) - le KELTROL T.F. est de la gomme xanthane ( ELCO) - le WITCONOL APM est du DPO 3 myrestil éther (WITCO) - l'EUXYL K 400 est du dibromo dicvanobutane phéno.xvéthanol (CALGON) - l'EDETATE DISODIQUE PH EU est du EDTA 2 Na (BASF).

Inglês

The results are recorded below: ______________________________________-10% TiO.sub.2 powder → UV A PF 4-2.4% ZnO → UV A PF 2.5-10% incorporated TiO.sub.2 /% → UV A PF 10decyl oleate + 2.4 ZnO______________________________________ The effect of the amount of each powder on the protection factor is evaluated below: ______________________________________-8% TiO.sub.2 /decyl oleate + 1.2% ZnO → UV A PF 6.5-10% TiO.sub.2 /decyl oleate + 1.2% ZnO → UV A PF 8.2-10% TiO.sub.2 /decyl oleate + 2.4% ZnO → UV A PF 10______________________________________ II--Stability with time and according to the method The procedure for measuring the stability with time of the compositions is as follows: The formulations based on incorporation or suspension of TiO.sub.2 +ZnO are stored at a warmth at 40 PF at room temperature and then after 1 month and 3 months at 40 C. are calculated.

Última atualização: 2014-12-03
Frequência de uso: 1
Qualidade:

Consiga uma tradução melhor através
4,401,923,520 de colaborações humanas

Usuários estão solicitando auxílio neste momento:



Utilizamos cookies para aprimorar sua experiência. Se avançar no acesso a este site, você estará concordando com o uso dos nossos cookies. Saiba mais. OK